Has COVID Swayed the Rise in Pneumococcal Disease in Spain?

An increase in the use of two types of antibiotics to treat COVID-19 may have contributed to a rise in antimicrobial-resistant strains of Streptococcus pneumoniae.

Related Keywords

Spain ,Spanish ,Mirian Domenech ,Spanish Agency Of Medicines ,National Center ,Spanish Pneumococcus Reference Laboratory ,Network Biomedical Research On Respiratory Diseases ,Health Institute ,Pneumococcus Reference Laboratory ,National Microbiology Center ,Network Biomedical Research ,Respiratory Diseases ,Meiji Pharma Spain ,Lancet Microbe ,Spanish Agency ,Medical Products ,European Medicines ,Coronavirus ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Uman Coronavirus Oc43 ,Cov Oc43 ,Uman Coronavirus 229e ,Cov 229e ,Pneumonia ,Antibiotic Resistance ,Antibiotics ,Igecycline ,Pandemic ,Inpatient Care ,Vaccine ,Antimicrobial Resistance ,Microbiology ,Microbiome ,Viral Illness ,Viral Pneumonia ,